OTCM
FUNI
Market cap1mUSD
Jul 09, Last price
0.02USD
1D
5.25%
1Q
-11.76%
Jan 2017
-92.31%
IPO
-94.83%
Name
Digipath Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Digipath, Inc., with its subsidiaries, offers essential laboratory testing for cannabis and hemp, primarily serving Nevada's licensed medical marijuana enterprises from its base in Las Vegas. Beyond these core analytical services, the company also provides comprehensive support to the broader cannabis industry, including educational programs, professional training, and news coverage. As a dedicated testing laboratory, Digipath analyzes various products such as cannabis, cannabis-infused items, hemp, and other botanical nutraceuticals, catering to cultivators, dispensaries, caregivers, producers, patients, and end-users of these botanical goods. A critical aspect of their operations involves rigorously screening medicinal and recreational cannabis for potential contaminants. This includes checks for residual solvents, moisture content, water activity, and visual integrity, alongside identifying pesticides, a spectrum of heavy metals (like mercury, arsenic, lead, cadmium, chromium, and nickel), biological toxins (including aflatoxin and ocratoxins), and a wide array of microbial contaminants (such as E. coli, salmonella, coliforms, aspergillus, gram-negative bacteria, total aerobic bacteria, mold, and yeast). Digipath, Inc. was established in 2010 and is headquartered in Las Vegas, Nevada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||